|
2024
|
G/S
|
Pharmaceutical compositions; pharmaceutical preparations; pharmaceutical preparations for rare di... |
|
|
Invention
|
A multiple unit oral dosage form of doxylamine succinate and pyridoxine hydrochloride free of tit... |
|
|
G/S
|
Biochemical and chemical preparations for medical use namely chemical reagents for medical purpos... |
|
|
G/S
|
Biochemical and chemical preparations for medical use, namely, chemical reagents for medical purp... |
|
|
G/S
|
Management of business projects, namely management of clinical trial projects, recruitment and se... |
|
|
G/S
|
Management of business projects, namely management of clinical trial projects in the nature of pr... |
|
|
G/S
|
Management of business projects, namely management of
clinical trial projects, recruitment and s... |
|
|
G/S
|
Business project management, That is, project management of clinical studies, recruitment and sel... |
|
2023
|
G/S
|
Biochemical and chemical preparations for medical use,
namely, chemical reagents for medical pur... |
|
|
Invention
|
Difluoro- and trifluoro-acetyl hydrazides as selective hdac6 inhibitors. The present invention re... |
|
|
Invention
|
1,3,4-oxadiazole derivatives as selective histone deacetylase 6 inhibitors. The present invention... |
|
|
Invention
|
Process for preparing {6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl... |
|
2022
|
G/S
|
Medicines to treat insomnia; sleep aid medicines; food
supplements used for insomnia and as slee... |
|
|
G/S
|
Pharmaceuticals, in particular supplements based on extracts
of hawthorn, lavender and hops for ... |
|
|
Invention
|
Use of somatostatin agonist in the treatment of sstr3 expressing tumors.
The present invention r... |
|
|
Invention
|
Use of somatostatin agonist in the treatment of sstr3 expressing tumors. The present invention re... |
|
|
Invention
|
Method to detect rna biomarkers.
The present invention relates a method based on mRNA biomarkers... |
|
|
Invention
|
Method to detect rna biomarkers. The present invention relates a method based on mRNA biomarkers ... |
|
|
G/S
|
Food supplements; Nutraceuticals; Probiotic supplements; Functional food for improvement of basal... |
|
|
Invention
|
A combination comprising a specific hdac6 inhibitor and at least one ctla4 checkpoint inhibitor. ... |
|
|
G/S
|
Pharmaceutical preparations; chemical and biochemical products for medical purposes; Biological p... |
|
|
G/S
|
Pharmaceuticals; Pharmaceutical specialities for use in treating mild to moderate dementia caused... |
|
2021
|
Invention
|
Novel oxadiazole-based selective hdac6 inhibitors.
The present invention relates to novel select... |
|
|
Invention
|
Novel oxadiazole-based selective hdac6 inhibitors. Compounds of formula (I) as selective inhibito... |
|
|
Invention
|
2-(4-((5-(benzo[b]thiophen-3-yl)-1h-tetrazol-1-yl)methyl)phenyl)-5-(difluoromethyl)-1,3,4-oxadiaz... |
|
|
G/S
|
Pharmaceutical drugs for alleviating symptoms of intermittent claudication in peripheral vascular... |
|
|
G/S
|
Pharmaceutical specialities; chemical and biochemical products for medical purposes; Biological p... |
|
|
G/S
|
Pharmaceutical specialities except antimycotics; chemical and biochemical products for medical pu... |
|
|
Invention
|
Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative sy... |
|
2020
|
G/S
|
Pharmaceutical specialities for use in treating mild to moderate dementia caused by Alzheimer's d... |
|
|
G/S
|
Medicine; Medicines for human purposes; Chemico-pharmaceutical preparations; Chemico-pharmaceutic... |
|
2019
|
G/S
|
Pharmaceuticals, namely pharmaceuticals containing a
combination of doxylamine and pyridoxine in... |
|
|
G/S
|
Pharmaceuticals, In particular supplements based on myo-inositol, folic acid and α-lactalbumin, f... |
|
|
G/S
|
Pharmaceuticals, In particular supplements based on myo-inositol, 1D-chiro-inositol, folic acid a... |
|
|
G/S
|
Pharmaceuticals, Namely pharmaceuticals containing a combination of doxylamine and pyridoxine ind... |
|
|
Invention
|
Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distributi... |
|
2018
|
G/S
|
Pharmaceuticals, in particular supplements based on extracts of hawthorn, lavender and hops for t... |
|
|
Invention
|
Selective hdac6 inhibitors. The present invention relates to novel benzohydroxamic compounds of f... |
|
|
Invention
|
Substituted benzamide derivatives and pharmaceutical compositions thereof useful as hdac6 inhibit... |
|
2017
|
G/S
|
Pharmaceutical products and more precisely supplements for
the treatment of hyperuricaemia; diet... |
|
|
Invention
|
Benzo-n-hydroxy amide compounds having antitumor activity. The present invention relates to new b... |
|
2016
|
Invention
|
Physically and chemically stable oral suspensions of givinostat. Physically and chemically stable... |
|
|
Invention
|
Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chlor... |
|
|
G/S
|
Pharmaceutical preparations for medical and veterinary use; Sanitary preparations for medical pur... |
|
2015
|
G/S
|
Pharmaceutical products and more precisely supplements to be
used for emesis and hyperemesis dis... |
|
|
G/S
|
Pharmaceutical preparations for use in cardiovascular treatments, thrombosis and ischemia treatme... |
|
|
G/S
|
Pharmaceutical drugs; Antitumor drugs; Compounds for treating cancer. |
|
|
G/S
|
Pharmaceutical preparations; dietetic substances adapted for
medical use; dietary foods and prod... |
|
|
G/S
|
Pharmaceutical drugs; Chemico-pharmaceutical preparations; Chemical preparations for pharmaceutic... |
|
|
G/S
|
Pharmaceutical and veterinary products; hygiene products for
medical use; dietetic substances fo... |
|
2014
|
Invention
|
Arginine and/or citrulline for use in the treatment and/or prevention of osteoarthritis. The pres... |
|
2013
|
G/S
|
Pharmaceutical, veterinary preparations; sanitary
preparations for medical purposes; dietetic fo... |
|
|
G/S
|
Pharmaceutical products; veterinary and sanitary products;
dietetic products for medical use and... |
|
2012
|
Invention
|
Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium ... |
|
2011
|
Invention
|
Use of histone deacetylase inhibitors for the care of philadephia-negative myeloproliferative syn... |
|
2010
|
Invention
|
Derivatives of n-hydroxybenzamide for treating hiv infections. Compound selected from 4-(2(S)-ben... |
|
|
Invention
|
Derivatives of n-hydroxybenzamide for treating hiv infections. Herein disclosed is a method for t... |
|
|
Invention
|
Iron (iii) caseinsuccinylate and method for the preparation thereof.
The present invention refer... |
|
|
Invention
|
Iron (iii) caseinsuccinylate and method for the preparation thereof. The present invention refers... |
|
|
Invention
|
Method for treating philadelphia-negative myeloproliferative syndromes. Method for treating Phila... |
|
|
Invention
|
Riluzole liquid emulsions. Physically and chemically stable liquid O/W and W/O emulsions of riluz... |
|
|
Invention
|
Riluzole aqueous suspensions. Physically and chemically stable aqueous oral suspensions of riluzo... |
|
|
Invention
|
Riluzole aqueous suspensions. Physically and chemically stable aqueous suspensions of riluzole ar... |
|
2008
|
Invention
|
Non-selective somatostatin analogues. Cyclohexapeptides of formula (I):
as defined herein. The c... |
